CN108936689A - Adjust the oral solution and preparation method thereof of immunity - Google Patents
Adjust the oral solution and preparation method thereof of immunity Download PDFInfo
- Publication number
- CN108936689A CN108936689A CN201810751480.3A CN201810751480A CN108936689A CN 108936689 A CN108936689 A CN 108936689A CN 201810751480 A CN201810751480 A CN 201810751480A CN 108936689 A CN108936689 A CN 108936689A
- Authority
- CN
- China
- Prior art keywords
- oral solution
- taurine
- purified water
- immunity
- calcium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229940100688 oral solution Drugs 0.000 title claims abstract description 44
- 230000036039 immunity Effects 0.000 title claims abstract description 43
- 238000002360 preparation method Methods 0.000 title claims abstract description 14
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims abstract description 78
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims abstract description 50
- 229960003080 taurine Drugs 0.000 claims abstract description 39
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 39
- 239000008213 purified water Substances 0.000 claims abstract description 37
- 239000000843 powder Substances 0.000 claims abstract description 28
- 239000004227 calcium gluconate Substances 0.000 claims abstract description 27
- 229960004494 calcium gluconate Drugs 0.000 claims abstract description 27
- 235000013927 calcium gluconate Nutrition 0.000 claims abstract description 27
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 claims abstract description 27
- 239000001527 calcium lactate Substances 0.000 claims abstract description 27
- 235000011086 calcium lactate Nutrition 0.000 claims abstract description 27
- NEEHYRZPVYRGPP-UHFFFAOYSA-L calcium;2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Ca+2].OCC(O)C(O)C(O)C(O)C([O-])=O.OCC(O)C(O)C(O)C(O)C([O-])=O NEEHYRZPVYRGPP-UHFFFAOYSA-L 0.000 claims abstract description 27
- 108010058846 Ovalbumin Proteins 0.000 claims abstract description 26
- 235000021552 granulated sugar Nutrition 0.000 claims abstract description 26
- 229940092253 ovalbumin Drugs 0.000 claims abstract description 26
- 239000004310 lactic acid Substances 0.000 claims abstract description 25
- 235000014655 lactic acid Nutrition 0.000 claims abstract description 25
- 229960002401 calcium lactate Drugs 0.000 claims abstract description 19
- 238000004519 manufacturing process Methods 0.000 claims abstract description 9
- 239000002994 raw material Substances 0.000 claims abstract description 4
- 238000011049 filling Methods 0.000 claims description 17
- 239000000706 filtrate Substances 0.000 claims description 14
- 238000010438 heat treatment Methods 0.000 claims description 14
- 238000003756 stirring Methods 0.000 claims description 14
- 229940041131 calcium lactate gluconate Drugs 0.000 claims description 8
- 230000002776 aggregation Effects 0.000 claims description 7
- 238000004220 aggregation Methods 0.000 claims description 7
- 239000006166 lysate Substances 0.000 claims description 7
- 108010000912 Egg Proteins Proteins 0.000 claims 1
- 102000002322 Egg Proteins Human genes 0.000 claims 1
- 239000006071 cream Substances 0.000 claims 1
- 210000000969 egg white Anatomy 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 5
- 208000033065 inborn errors of immunity Diseases 0.000 abstract description 3
- 208000028529 primary immunodeficiency disease Diseases 0.000 abstract description 3
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 2
- 230000002155 anti-virotic effect Effects 0.000 abstract description 2
- 239000000463 material Substances 0.000 abstract description 2
- 230000008092 positive effect Effects 0.000 abstract description 2
- 230000002195 synergetic effect Effects 0.000 abstract description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 11
- 229960005069 calcium Drugs 0.000 description 11
- 229910052791 calcium Inorganic materials 0.000 description 11
- 239000011575 calcium Substances 0.000 description 11
- 230000006870 function Effects 0.000 description 7
- 238000000034 method Methods 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 230000001954 sterilising effect Effects 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 230000018109 developmental process Effects 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 235000013402 health food Nutrition 0.000 description 4
- 150000002632 lipids Chemical class 0.000 description 4
- 108090000765 processed proteins & peptides Proteins 0.000 description 4
- 102000004196 processed proteins & peptides Human genes 0.000 description 4
- 230000028327 secretion Effects 0.000 description 4
- 108010088751 Albumins Proteins 0.000 description 3
- 102000009027 Albumins Human genes 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 229920001184 polypeptide Polymers 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- WBWWGRHZICKQGZ-HZAMXZRMSA-N taurocholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCCS(O)(=O)=O)C)[C@@]2(C)[C@@H](O)C1 WBWWGRHZICKQGZ-HZAMXZRMSA-N 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 208000002177 Cataract Diseases 0.000 description 2
- 206010061598 Immunodeficiency Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 210000000941 bile Anatomy 0.000 description 2
- 210000001772 blood platelet Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 230000015271 coagulation Effects 0.000 description 2
- 238000005345 coagulation Methods 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 230000002182 neurohumoral effect Effects 0.000 description 2
- 230000035790 physiological processes and functions Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 208000034767 Hypoproteinaemia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102000003746 Insulin Receptor Human genes 0.000 description 1
- 108010001127 Insulin Receptor Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010057249 Phagocytosis Diseases 0.000 description 1
- 102000001253 Protein Kinase Human genes 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000005864 Sulphur Substances 0.000 description 1
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003044 adaptive effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 230000003288 anthiarrhythmic effect Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 150000001576 beta-amino acids Chemical class 0.000 description 1
- 239000003613 bile acid Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000005013 brain tissue Anatomy 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 210000004413 cardiac myocyte Anatomy 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 230000004700 cellular uptake Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 210000003792 cranial nerve Anatomy 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000008260 defense mechanism Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 210000000750 endocrine system Anatomy 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 230000034659 glycolysis Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000000960 hypophysis hormone Substances 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 230000007087 memory ability Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 230000005709 nerve cell growth Effects 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 230000004203 pancreatic function Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 210000001539 phagocyte Anatomy 0.000 description 1
- 230000008782 phagocytosis Effects 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 108060006633 protein kinase Proteins 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 230000009711 regulatory function Effects 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 230000004243 retinal function Effects 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 208000019116 sleep disease Diseases 0.000 description 1
- 208000022925 sleep disturbance Diseases 0.000 description 1
- 230000003860 sleep quality Effects 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 230000004382 visual function Effects 0.000 description 1
- 235000011478 zinc gluconate Nutrition 0.000 description 1
- 239000011670 zinc gluconate Substances 0.000 description 1
- 229960000306 zinc gluconate Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
The invention discloses the oral solution and preparation method thereof for adjusting immunity, every 10000ml oral solution is composed of the following components: ovalbumin powder 200-600g, calcium lactate 470-870g; calcium gluconate 100-500g, taurine 10-40g, white granulated sugar 800-1600g; lactic acid 5-25ml, surplus are purified water；Using ovalbumin powder, calcium lactate, calcium gluconate, taurine as raw material, white granulated sugar, lactic acid are auxiliary material, and good mouthfeel is easy to receive, it is preferable to take compliance for children；And pass through all component compatibilities of the oral solution, synergistic effect, it brings out the best in each other, both the non-specific immunity of human body can be improved, specific immunity ability can be improved again, but also there is antibacterial, anti-virus ability, effect diversity reduces risk to hypoimmunity crowd and thus bring reduces social medical treatment cost, raising social production efficiency also has positive effect.
Description
Technical field
The present invention relates to technical field of health care food, in particular to a kind of oral solution for adjusting immunity and its preparation side
Method.
Background technique
Immunity is the defense mechanism of human body itself, be human bioequivalence and eliminate external intrusion any foreign matter (as virus,
Bacterium etc.), processing aging, damage, death, the own cells of denaturation and identification and processing vivo mutations cell and virus infection
The ability of cell.Immunology Today thinks that immunity is human bioequivalence and the physiological reaction for excluding " dissident ", executes this in human body
One function is immune system.When a variety of causes prevents immune system from normally playing protective effect and to be reflected as immunity low
When lower, human body easily incur bacterium, virus, fungi etc. infection, therefore hypoimmunity most directly show be exactly it is liable to illness,
And because of frequent illness, aggravated the consumption of body, thus generally have a delicate constitution, malnutritive, apathetic, fatigue and weak,
The performance such as loss of appetite, sleep disturbance, if things go on like this will lead to physical and intellectual depauperation, also easily induce major disease.Cause
This, immunocompromised person is daily to be exempted from by improving diet, physical training and taking suitable health food to improve itself
Epidemic disease power.
And immunity can be divided into nospecific immunity and specific immunity, wherein nospecific immunity is also known as natural
Immune or inherent immunity, nospecific immunity have the characteristics that sphere of action is wide, reaction is fast, relatively stable, has heredity, work as antigen
Substance is invaded after body, and what is played a role first is nospecific immunity, then generates specific immunity.Therefore, non-specific
Property it is immune be all immune protection abilities basis.Specific immunity is also known as adaptive immune, is through acquired infection or artificial prevention
It is inoculated with and obtains body and resist infection ability, usually just formed after the stimulation of the antigenic substances such as microorganism, and can be with this
Antigen plays specific reaction.
Through in State Food and Drug Administration website data library inquiry and market on-site inspection, China's approved
The health food improved the immunity of the human body has multiple kinds, the predominantly liquid such as the solid pharmaceutical preparations such as tablet, capsule and oral solution
Preparation, these health foods generally use integration of drinking and medicinal herbs or can be used for the Chinese medicine of health food, then be equipped with amino acid powder or other
Nutrient, such as zinc gluconate, kind formula is more single, cannot nospecific immunity and specificity to needed by human body
Immune to carry out comprehensive adjustment, health-care effect is not ideal enough.
Summary of the invention
In view of this, the present invention provides the oral solution and preparation method thereof for adjusting immunity, human body non-specificity is exempted from
Epidemic disease and specific immunity have facilitation, can effectively improve the immunity of immunocompromised person.
The oral solution of adjusting immunity of the invention, every 10000ml oral solution are composed of the following components: ovalbumin powder
200-600g, calcium lactate 470-870g, calcium gluconate 100-500g, taurine 10-40g, white granulated sugar 800-1600g, lactic acid
5-25ml, surplus are purified water.
Preferably, the oral solution of immunity is adjusted, every 10000ml oral solution is composed of the following components: ovalbumin powder
300-500g, calcium lactate 570-770g, calcium gluconate 200-400g, taurine 20-30g, white granulated sugar 1000-1400g, lactic acid
10-20ml, surplus are purified water.
Preferably, the oral solution of immunity is adjusted, every 10000ml oral solution is composed of the following components: ovalbumin powder
400g, calcium lactate 670g, calcium gluconate 300g, taurine 25g, white granulated sugar 1200g, lactic acid 15ml, surplus are purified water.
Wherein, albumin polypeptide is rich in ovalbumin powder, albumin polypeptide can be dissolved in water, abundant without bad smell
Without visible foreign and precipitating after dissolution, and albumin polypeptide is made of the peptides of different aminoacids sequence, shows extensive life
Regulatory function is managed, there is adjustment immunity, improve efficiency of food conversion, adjustment intestinal flora, promote the substances such as calcium, iron, nucleic acid
It absorbs, improves Hypoproteinemia, promotes postoperative rehabilitation and other effects after being ill.
Taurine is a kind of beta-amino acids, has extensive physiological function, and such as (1) improves endocrinosity, enhances human body
Immune: taurine can promote pituitary hormone secretion, pancreas function be activated, so as to improve the state of organism endocrine system, to machine
Body is metabolized with beneficial adjusting；And have the function of promote organism immunity enhancing and it is antifatigue；(2) promote infant brain
Tissue and intellectual development: taurine in the rich content, widely distributed of intracerebral, can be obviously promoted nervous system growth and development and
Cell Proliferation, differentiation, and be in dose dependent, it plays an important role in cranial nerve cell growth course；(3) nerve is improved to pass
It leads and visual function: if infant lacks taurine, it may occur that retinal function disorder, the disease of long-term PN solution
People can make patient's retina current graph change if not having taurine in infusion, only supplement the taurine ability of large dosage
Correct this variation；(4) prevent cardiovascular disease: taurine can inhibit platelet aggregation in the circulatory system, reduce blood lipid, keep
Human normal blood pressure and prevent artery sclerosis；There is protective effect to cardiac muscle cell, it can anti-arrhythmia；To reducing, gallbladder in blood is solid
Alcohol content has special efficacy, can treat heart failure；(5) influence the absorption of lipid: the effect of taurine is pre- bile in liver
Acid combines and forms taurocholate, and taurocholate is required to the absorption of lipid in alimentary canal；Taurocholate can increase lipid and
The dissolubility of cholesterol releases cholestasia, reduces the cytotoxicity of certain free bile acids, inhibit the shape of cholesterol stone
At increase bile flow etc.；(6) influence glycometabolism: taurine can bind to the insulin receptor, and promotes cellular uptake and utilizes Portugal
Grape sugar, accelerates glycolysis, reduces blood sugar concentration；(7) inhibit the occurrence and development of cataract: taurine, which has, adjusts crystal osmotic pressure
It can inhibit the occurrence and development of cataract with important function, the supplementation of taurine such as anti-oxidant；(8) improve the function of memory: in ox sulphur
It is found in the animal experiment study of acid and brain growth relationship, taurine can promote the learning and memory ability of big white mouse；Supplement is suitable
Learning and memory speed not only can be improved in amount taurine, but also the accuracy of learning and memory can be improved, and to nerveous system
The anti-aging of system also has certain effect.
It is rich in calcium constituent in calcium lactate and calcium gluconate, using the powerful physiological function of calcium constituent, improves human immunity
Power, (1) calcium participate in immune response: accelerating the phagocytosis of phagocyte, can increase the immunity of human body；(2) calcium participates in mind
Through muscle stress process: neurohumoral release can be promoted, adjust the secretion of hormone, maintain conduction, the heart of nerve impulse
Bounce, calcium also has sedation；(3) calcium can also activate corresponding protein kinase, promote certain intracellular proteins in vivo
Phosphorylation events；(4) calcium also promotes the secretion of endo-exocrine gland, and neurohumoral secretion promotes Glycogen synthesis, decomposition and electricity
Solve the transhipment of matter；(5) calcium may also participate in the solidification of blood: calcium promotes coagulation process directly as blood coagulation composite factor, can be with
The release for directly facilitating blood platelet promotes platelet-mediated coagulation process；(6) calcium can also reduce the permeability of capillary,
It prevents liquid from oozing out, controls inflammation and oedema.
The invention also discloses a kind of methods of oral solution for preparing above-mentioned adjusting immunity, comprising the following steps:
Raw material is weighed by each component content；
Ovalbumin powder is merged with taurine；Calcium lactate and calcium gluconate are merged, and add up the pure of volume 30%
Change water, dissolves by heating, it is spare；By the purified water of white granulated sugar aggregation volume 30%, dissolve by heating, it is spare；
Merge above-mentioned lysate, stirs evenly, it is spare；
Add purified water constant volume, while frame lactic acid tune mouthfeel, stir evenly, filters, obtain filtrate, it is spare；
Filtrate is filling to obtain oral solution.
Further, above-mentioned all steps carry out in 300,000 grades of clear production areas.
Beneficial effects of the present invention: the oral solution and preparation method thereof of adjusting immunity of the invention, with ovalbumin powder,
Calcium lactate, calcium gluconate, taurine are raw material, and white granulated sugar, lactic acid are auxiliary material, and good mouthfeel comes particularly with children
It says, is easy to receive, it is preferable to take compliance；And by all component compatibilities of the oral solution, synergistic effect brings out the best in each other, both can be with
The non-specific immunity of human body is improved, and specific immunity ability can be improved, but also there is antibacterial, anti-virus ability,
Effect diversity reduces risk to hypoimmunity crowd and thus bring reduces social medical treatment cost, raising society
Meeting production efficiency also has positive effect.
Specific embodiment
The technical scheme in the embodiment of the invention is clearly and completely described below, it is clear that described embodiment
Only a part of the embodiments of the present invention, instead of all the embodiments.Based on the embodiment of the present invention, the common skill in this field
Art personnel every other embodiment obtained without making creative work belongs to the model that the present invention protects
It encloses.
It in addition, the technical solution between each embodiment can be combined with each other, but must be with ordinary skill
Based on personnel can be realized, this technical side will be understood that when the combination of technical solution appearance is conflicting or cannot achieve
The combination of case is not present, also not within the scope of protection required by the present invention.
The present invention proposes a kind of oral solution for adjusting immunity.
Embodiment one
Every 10000ml oral solution is composed of the following components: ovalbumin powder 200g, calcium lactate 470g, calcium gluconate
100g, taurine 10g, white granulated sugar 800g, lactic acid 5ml, surplus are purified water.
Every 10000ml oral solution provided in this embodiment the preparation method is as follows:
(1) precise ovalbumin powder 200g, calcium lactate 470g, calcium gluconate 100g, taurine 10g, white granulated sugar
800g, lactic acid 5ml, 10000ml purified water are spare；
(2) ovalbumin powder is merged with taurine；Calcium lactate and calcium gluconate are merged, and add up volume 30%
Purified water dissolves by heating, spare；By the purified water of white granulated sugar aggregation volume 30%, dissolve by heating, it is spare；
(3) merge above-mentioned lysate, stir evenly, it is spare；
(4) add purified water constant volume, while frame lactic acid tune mouthfeel, stir evenly, filter, obtain filtrate, it is spare；
(5) filtrate is filling obtains oral solution.
Above-mentioned all steps carry out in 300,000 grades of clear production areas；Wherein, quantitative filling is 10ml/ branch, and in quantitative filling
Sterilizing 45 minutes is carried out after dress at 105 DEG C.
Embodiment two
Every 10000ml oral solution is composed of the following components: ovalbumin powder 600g, calcium lactate 870g, calcium gluconate
500g, taurine 40g, white granulated sugar 1600g, lactic acid 25ml, surplus are purified water.
Every 10000ml oral solution provided in this embodiment the preparation method is as follows:
(1) precise ovalbumin powder 600g, calcium lactate 870g, calcium gluconate 500g, taurine 40g, white granulated sugar
1600g, lactic acid 25ml, 10000ml purified water are spare；
(2) ovalbumin powder is merged with taurine；Calcium lactate and calcium gluconate are merged, and add up volume 30%
Purified water dissolves by heating, spare；By the purified water of white granulated sugar aggregation volume 30%, dissolve by heating, it is spare；
(3) merge above-mentioned lysate, stir evenly, it is spare；
(4) add purified water constant volume, while frame lactic acid tune mouthfeel, stir evenly, filter, obtain filtrate, it is spare；
(5) filtrate is filling obtains oral solution.
Above-mentioned all steps carry out in 300,000 grades of clear production areas；Wherein, quantitative filling is 10ml/ branch, and in quantitative filling
Sterilizing 45 minutes is carried out after dress at 105 DEG C.
Embodiment three
Every 10000ml oral solution is composed of the following components: ovalbumin powder 300g, calcium lactate 570g, calcium gluconate
200g, taurine 20g, white granulated sugar 1000g, lactic acid 10ml, surplus are purified water.
Every 10000ml oral solution provided in this embodiment the preparation method is as follows:
(1) precise ovalbumin powder 300g, calcium lactate 570g, calcium gluconate 200g, taurine 20g, white granulated sugar
1000g, lactic acid 10ml, 10000ml purified water are spare；
(2) ovalbumin powder is merged with taurine；Calcium lactate and calcium gluconate are merged, and add up volume 30%
Purified water dissolves by heating, spare；By the purified water of white granulated sugar aggregation volume 30%, dissolve by heating, it is spare；
(3) merge above-mentioned lysate, stir evenly, it is spare；
(4) add purified water constant volume, while frame lactic acid tune mouthfeel, stir evenly, filter, obtain filtrate, it is spare；
(5) filtrate is filling obtains oral solution.
Above-mentioned all steps carry out in 300,000 grades of clear production areas；Wherein, quantitative filling is 10ml/ branch, and in quantitative filling
Sterilizing 45 minutes is carried out after dress at 105 DEG C.
Example IV
Every 10000ml oral solution is composed of the following components: ovalbumin powder 500g, calcium lactate 770g, calcium gluconate
400g, taurine 30g, white granulated sugar 1400g, lactic acid 20ml, surplus are purified water.
Every 10000ml oral solution provided in this embodiment the preparation method is as follows:
(1) precise ovalbumin powder 500g, calcium lactate 770g, calcium gluconate 400g, taurine 30g, white granulated sugar
1400g, lactic acid 20ml, 10000ml purified water are spare；
(2) ovalbumin powder is merged with taurine；Calcium lactate and calcium gluconate are merged, and add up volume 30%
Purified water dissolves by heating, spare；By the purified water of white granulated sugar aggregation volume 30%, dissolve by heating, it is spare；
(3) merge above-mentioned lysate, stir evenly, it is spare；
(4) add purified water constant volume, while frame lactic acid tune mouthfeel, stir evenly, filter, obtain filtrate, it is spare；
(5) filtrate is filling obtains oral solution.
Above-mentioned all steps carry out in 300,000 grades of clear production areas；Wherein, quantitative filling is 10ml/ branch, and in quantitative filling
Sterilizing 45 minutes is carried out after dress at 105 DEG C.
Embodiment five
Every 10000ml oral solution is composed of the following components: ovalbumin powder 400g, calcium lactate 670g, calcium gluconate
300g, taurine 25g, white granulated sugar 1200g, lactic acid 15ml, surplus are purified water.
Every 10000ml oral solution provided in this embodiment the preparation method is as follows:
(1) precise ovalbumin powder 400g, calcium lactate 670g, calcium gluconate 300g, taurine 25g, white granulated sugar
1200g, lactic acid 15ml, 10000ml purified water are spare；
(2) ovalbumin powder is merged with taurine；Calcium lactate and calcium gluconate are merged, and add up volume 30%
Purified water dissolves by heating, spare；By the purified water of white granulated sugar aggregation volume 30%, dissolve by heating, it is spare；
(3) merge above-mentioned lysate, stir evenly, it is spare；
(4) add purified water constant volume, while frame lactic acid tune mouthfeel, stir evenly, filter, obtain filtrate, it is spare；
(5) filtrate is filling obtains oral solution.
Above-mentioned all steps carry out in 300,000 grades of clear production areas；Wherein, quantitative filling is 10ml/ branch, and in quantitative filling
Sterilizing 45 minutes is carried out after dress at 105 DEG C.
Experimental example
The oral solution of adjusting immunity of the invention, with 10ml/ branch, three times a day, and one every time, 30 days as one therapeutic course,
Follow-up observation is carried out to 50 users, whether its immunity of main detection improves with whether human-body fatigue sense alleviates two sides
Face, as follows as the result is shown:
After taking 1 course for the treatment of of oral solution of adjusting immunity of the invention, most of user feels 50 users
There is very big alleviation to physical fatigue sense, evening sleep quality is greatly enhanced, and is detected its immunity and be significantly increased,
Such as gastritis, mazoitis have very big alleviation.
Treatment standard:
Recovery from illness -- symptom completely disappears, and function of human body restores normal, and clinical examination index is normal.
It is effective -- cardinal symptom disappears, and function of human body is restored substantially, and clinical examination index is normal.
Effectively -- cardinal symptom disappears substantially, and main human's function and clinical examination index make moderate progress.
In vain -- compared with pre-treatment, various aspects are without improvement.
By statistics, 20 (40%) of fully recovering in 50 users, effective 17 (34%), effective 12 (24%), nothing
Imitate 1 (2%).
Finally, it is stated that the above examples are only used to illustrate the technical scheme of the present invention and are not limiting, although referring to compared with
Good embodiment describes the invention in detail, those skilled in the art should understand that, it can be to skill of the invention
Art scheme is modified or replaced equivalently, and without departing from the objective and range of technical solution of the present invention, should all be covered at this
In the scope of the claims of invention.
Claims (5)
1. a kind of oral solution for adjusting immunity, it is characterised in that: every 10000ml oral solution is composed of the following components: egg white egg
White powder 200-600g, calcium lactate 470-870g, calcium gluconate 100-500g, taurine 10-40g, white granulated sugar 800-1600g,
Lactic acid 5-25ml, surplus are purified water.
2. the oral solution according to claim 1 for adjusting immunity, it is characterised in that: every 10000ml oral solution is by following
Group is grouped as: ovalbumin powder 300-500g, calcium lactate 570-770g, calcium gluconate 200-400g, taurine 20-30g, white
Granulated sugar 1000-1400g, lactic acid 10-20ml, surplus are purified water.
3. it is according to claim 1 or 2 adjust immunity oral solution, it is characterised in that: every 10000ml oral solution by with
The following group is grouped as: ovalbumin powder 400g, calcium lactate 670g, calcium gluconate 300g, taurine 25g, white granulated sugar 1200g, cream
Sour 15ml, surplus are purified water.
4. a kind of preparation method of the oral solution of adjusting immunity described in claim 1-3 any claim, feature exist
In: the following steps are included:
Raw material is weighed by each component content；
Ovalbumin powder is merged with taurine；Calcium lactate and calcium gluconate are merged, and add up the purified water of volume 30%,
It dissolves by heating, it is spare；By the purified water of white granulated sugar aggregation volume 30%, dissolve by heating, it is spare；
Merge above-mentioned lysate, stirs evenly, it is spare；
Add purified water constant volume, while frame lactic acid tune mouthfeel, stir evenly, filters, obtain filtrate, it is spare；
Filtrate is filling to obtain oral solution.
5. the preparation method according to claim 4, it is characterised in that: above-mentioned all steps 300,000 grades of clear production areas into
Row.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810751480.3A CN108936689A (en) | 2018-07-10 | 2018-07-10 | Adjust the oral solution and preparation method thereof of immunity |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810751480.3A CN108936689A (en) | 2018-07-10 | 2018-07-10 | Adjust the oral solution and preparation method thereof of immunity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN108936689A true CN108936689A (en) | 2018-12-07 |
Family
ID=64483701
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810751480.3A Pending CN108936689A (en) | 2018-07-10 | 2018-07-10 | Adjust the oral solution and preparation method thereof of immunity |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108936689A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112545984A (en) * | 2020-12-18 | 2021-03-26 | 哈药集团三精制药有限公司 | Compound calcium gluconate oral solution and preparation method thereof |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1090775A (en) * | 1993-02-08 | 1994-08-17 | 杨培康 | Children's nutritious liquid for invigorating brain, eyesight and body |
| WO2012050895A1 (en) * | 2010-09-28 | 2012-04-19 | Lisa Geng | Methods for treating neurological disorders using nutrient compositions |
| CN102429235A (en) * | 2011-11-11 | 2012-05-02 | 完美（中国）有限公司 | Health care food with functions of relieving physical fatigue and enhancing immunity |
| CN103735540A (en) * | 2014-01-10 | 2014-04-23 | 新疆特丰药业股份有限公司 | Calcium gluconate aqueous solution with high calcium content and preparation method thereof |
| CN103976216A (en) * | 2014-05-20 | 2014-08-13 | 广东太阳神集团有限公司 | Health-protection product with functions of supplementing calcium and enhancing immunity and preparation method for health-protection product |
| CN106804725A (en) * | 2015-11-30 | 2017-06-09 | 青岛顺昕电子科技有限公司 | A kind of person in middle and old age's strong bone formula milk |
| CN107912535A (en) * | 2016-10-11 | 2018-04-17 | 李西平 | A kind of bovine colostrum composite powder and preparation method thereof |
-
2018
- 2018-07-10 CN CN201810751480.3A patent/CN108936689A/en active Pending
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1090775A (en) * | 1993-02-08 | 1994-08-17 | 杨培康 | Children's nutritious liquid for invigorating brain, eyesight and body |
| WO2012050895A1 (en) * | 2010-09-28 | 2012-04-19 | Lisa Geng | Methods for treating neurological disorders using nutrient compositions |
| CN102429235A (en) * | 2011-11-11 | 2012-05-02 | 完美（中国）有限公司 | Health care food with functions of relieving physical fatigue and enhancing immunity |
| CN103735540A (en) * | 2014-01-10 | 2014-04-23 | 新疆特丰药业股份有限公司 | Calcium gluconate aqueous solution with high calcium content and preparation method thereof |
| CN103976216A (en) * | 2014-05-20 | 2014-08-13 | 广东太阳神集团有限公司 | Health-protection product with functions of supplementing calcium and enhancing immunity and preparation method for health-protection product |
| CN106804725A (en) * | 2015-11-30 | 2017-06-09 | 青岛顺昕电子科技有限公司 | A kind of person in middle and old age's strong bone formula milk |
| CN107912535A (en) * | 2016-10-11 | 2018-04-17 | 李西平 | A kind of bovine colostrum composite powder and preparation method thereof |
Non-Patent Citations (2)
| Title |
|---|
| SFD: "皓宇牌卵清蛋白牛磺酸钙口服液保健功能", 《快乐多资讯网，HTTPS://WWW.KUAILEDO.COM/BJPCX/020721586.HTML》 * |
| 江西皓宇生物科技有限公司: "卵清蛋白牛磺酸钙口服液-20支装", 《江西皓宇生物科技有限公司官方网站产品展示，HTTP://WWW.JXKFHY.COM/PRODUCTSHOW.PHP?PID=5&CID=26&ID=54》 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112545984A (en) * | 2020-12-18 | 2021-03-26 | 哈药集团三精制药有限公司 | Compound calcium gluconate oral solution and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN110037268A (en) | A kind of beautifying face and moistering lotion jelly and preparation method thereof improving sleep | |
| CN108543020A (en) | A kind of medicinal health-care preparation and preparation method thereof for improving sleep | |
| CN102160664A (en) | Nutritious drink for children | |
| Yampolsky et al. | Apricot (lat. Prunus armeniaca Lin.) | |
| CN109820905A (en) | A kind of pharmaceutical composition and its application for treating insomnia | |
| CN102441070B (en) | Composition for alleviating eye fatigue | |
| CN105661547A (en) | Probiotics and Bombyx mori compounded diabetic patient nutritional supplement | |
| CN1315418C (en) | Instant drinking powder contg. black-fungus, oatmeal and spirulina, and its prepn. method | |
| CN103919227A (en) | Corn oligopeptide beverage with function of enhancing memory ability and production technology thereof | |
| CN108635461A (en) | Dry eyes atomized liquid | |
| CN109170470A (en) | A kind of solid beverage and preparation method thereof for treating diabetes | |
| CN1101700C (en) | Polypeptide oral liquor | |
| CN108936689A (en) | Adjust the oral solution and preparation method thereof of immunity | |
| CN103719864A (en) | Blood glucose-reducing natto combined capsule and preparation method thereof | |
| CN102119939B (en) | Angiosperm bee pollen water extract for treating fatty liver and preparation method and application thereof | |
| CN108771246B (en) | Composition for improving immunity and restoring physiological function of patients after operation or chemotherapy | |
| CN104225228B (en) | A kind of Chinese medicine preparation for being used to adjust blood glucose | |
| CN1528182A (en) | Health-care food and preparing method thereof | |
| CN105748520A (en) | Compound preparation for treating ischemic optic neuropathy and preparation method of compound preparation | |
| CN104621574A (en) | Formula food suitable for diabetic patients and preparation method thereof | |
| CN1104519A (en) | Nutriment for improving visual ability | |
| CN109875048A (en) | Eyeshield composition and its application | |
| CN1241486C (en) | Method for preparing health-care milk powder with food sleeping-care function contg. meilatoning | |
| CN104413195A (en) | Eichhornia-crassipes blood-sugar-reducing tea and preparation method thereof | |
| JPS61239855A (en) | Food for improving physical constitution |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20181207 |
|
| RJ01 | Rejection of invention patent application after publication |